InvestorsHub Logo
Followers 22
Posts 888
Boards Moderated 0
Alias Born 05/09/2012

Re: TOB post# 40221

Monday, 09/09/2013 7:14:15 AM

Monday, September 09, 2013 7:14:15 AM

Post# of 403051
Wow, quite a development. Will certainly want to hear more about the Kevetrin developments as noted by TOB from the presentation slides. If it's true that they are stabilizing cancer progression below 75mg, well, I think we can all draw the same conclusions. I have to wonder if they are positioning themselves for a buyout at a very very high price with the new acquisition and mid-later stage trials planned in combination with what appears to be incredible efficacy of Kevetrin at low doses.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News